CS
ALXA

Credit Suisse’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Credit Suisse’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-771,753
Closed -$374K – 4450
2016
Q1 		$374K Sell
771,753
-6,344
-0.8% -$2.78K ﹤0.01% 3405
2015
Q4 		$545K Sell
778,097
-5,245
-0.7% -$5.41K ﹤0.01% 3315
2015
Q3 		$964K Sell
783,342
-523
-0.1% -$611 ﹤0.01% 2855
2015
Q2 		$855K Sell
783,865
-4,773
-0.6% -$7.16K ﹤0.01% 3316
2015
Q1 		$1.63M Sell
788,638
-1,505
-0.2% -$3.09K ﹤0.01% 2558
2014
Q4 		$1.18M Buy
790,143
+1,263
+0.2% +$2.25K ﹤0.01% 2997
2014
Q3 		$1.84M Sell
788,880
-1,475
-0.2% -$5.63K ﹤0.01% 2560
2014
Q2 		$3.61M Sell
790,355
-292
-0% -$1.26K ﹤0.01% 2237
2014
Q1 		$3.5M Buy
790,647
+9,831
+1% +$50.4K ﹤0.01% 2055
2013
Q4 		$3.69M Sell
780,816
-191
-0% -$937 ﹤0.01% 2090
2013
Q3 		$4M Buy
781,007
+126,715
+19% +$596K ﹤0.01% 1825
2013
Q2 		$2.84M Buy
+654,292
New +$2.97M ﹤0.01% 2012

Credit Suisse's ALXA Position: Q2 2016 in Review

Credit Suisse sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 771,753 shares — an estimated $374K sold.

Credit Suisse first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $4M in Q3 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Credit Suisse reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Credit Suisse sold 771,753 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $374K.
  • Credit Suisse first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Credit Suisse's Alexza Pharmaceuticals Inc position peaked at $4M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.